Thymalfasin


Concise Prescribing Info
Indications/Uses
Chronic hepatitis B and C.
Dosage/Direction for Use
Adult : SC 1.6 mg twice wkly, up to 12 mth.
Dosage Details
Subcutaneous
Chronic hepatitis B, Chronic hepatitis C
Adult: 1.6 mg twice wkly, up to 12 mth; for patients <40 kg: 40 mcg/kg. To be used alone or with interferon for chronic hepatitis B; and with interferon for chronic hepatitis C.
Reconstitution
Reconstitute the powder with 1 ml of the provided diluent (sterile water for inj) before admin.
Contraindications
Patients who are deliberately immunosuppressed e.g. organ transplant patients.
Special Precautions
Caution when used with other immunomodulating drugs.
Adverse Reactions
Local discomfort at the inj site, erythema, transient muscle atrophy, rash, polyarthralgia with hand oedema.
Action
Description: Thymalfasin is a thymus hormone. It exerts its immunomodulating effects mainly by enhancing the T cell activity. It may be used alone or with interferon as an immunomodulator for the treatment of chronic hepatitis B and C.
Pharmacokinetics:
Excretion: Half-life: About 2 hr.
Storage
Store between 2-8°C. Reconstituted inj should be used immediately.
Disclaimer: This information is independently developed by MIMS based on Thymalfasin from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
  • Zadaxin
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in